Subcutaneous Defibrillator Multi-Dipole Signal Processing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Subcutaneous implantable cardiac devices face challenges in signal processing due to reduced signal-to-noise ratio and increased energy requirements for defibrillation, leading to difficulties in detecting tachyarrhythmia and risk of inappropriate shocks from oversensing noise or P/T waves.
Innovation Solution
A subcutaneous implantable medical device with a subcutaneous lead comprising multiple sensing electrodes forming dipoles, where the first dipole is shorter than the second, allowing for improved detection of R waves and reduction of noise exposure, and a controller that determines a criterion of similarity between signals from both dipoles to differentiate tachyarrhythmia from noise or P/T wave oversensing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If subcutaneous leads are used instead of intracardiac leads, then the risk of systemic infection is eliminated and lead extraction becomes safer, but the signal-to-noise ratio of recorded signals is reduced
Solution Approach 1:
The patent transitions from single-dipole signal acquisition to multi-dipole signal acquisition. By using multiple dipoles (first dipole with first signal, second dipole with second signal) and comparing signals across different spatial dimensions, the system achieves better noise rejection while maintaining the safety advantages of subcutaneous placement.
Solution Approach 2:
The patent combines signals from multiple dipoles to improve detection accuracy. By merging the information from the first dipole and second dipole, the system enhances the signal-to-noise ratio through signal integration and comparison, allowing reliable tachyarrhythmia detection despite the inherent noise challenges of subcutaneous placement.
2Reliability
If subcutaneous leads are used instead of intracardiac leads, then lead extraction becomes less traumatic with no mortality risk, but the energy required for successful defibrillation increases
Solution Approach 1:
The patent divides the defibrillation function into multiple electrode segments (first defibrillation electrode, second defibrillation electrode) that work in conjunction with the sensing dipoles. This segmentation allows for more efficient energy delivery by creating optimized current pathways through the tissue, potentially reducing the total energy required for successful defibrillation.
3Reliability
If subcutaneous signals are used for tachyarrhythmia detection, then the P waves and T waves are larger relative to R waves making detection more difficult, but using intracardiac leads exposes patients to infection risks and vein occlusion
Solution Approach 1:
The patent introduces signal processing algorithms as an intermediary between the raw subcutaneous signals and the tachyarrhythmia detection decision. By using automated algorithms to analyze the multi-dipole signals, identify R waves, calculate R-R intervals, and distinguish true tachyarrhythmia from oversensing, the system overcomes the difficulty of detecting R-R intervals in subcutaneous signals where P and T waves are enlarged.
4Device complexity
If conventional signal processing algorithms are used for subcutaneous signals, then the device complexity remains similar to intracardiac devices, but the risk of over-detection or oversensing of noise increases
Solution Approach 1:
The patent implements feedback mechanisms where the detection algorithm continuously monitors signals from multiple dipoles, compares detected events against expected patterns, and adjusts its interpretation accordingly. The system uses feedback from the multi-dipole configuration to verify detections and reduce false positives, maintaining reliability while managing the complexity of subcutaneous signal processing.
Data Source
AI summary
A subcutaneous implantable active medical device, in particular a subcutaneous cardiac defibrillator, comprising a housing and a subcutaneous implantable lead connected to the housing. The subcutaneous implantable lead comprises a plurality of sensing electrodes forming at least two dipoles from which at least two electrical signals are collected concurrently. The first dipole having a first length less than a second length of the second dipole. The subcutaneous implantable active medical device further comprises a controller configured to determine whether or not tachyarrhythmia is present by determining a criterion of similarity based on the electrical signals collected concurrently via the first dipole and via the second dipole during a defined series of cardiac cycles that is such that detection of a depolarization peak, corresponding to detection of an R wave, is performed via the first dipole.